Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 9 de 9
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
1.
Bull Exp Biol Med ; 177(2): 190-196, 2024 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-39096448

RESUMEN

This study aimed to investigate the cardioprotective effect of quinacrine in an in vivo model of myocardial ischemia/reperfusion injury. A 30-min regional myocardial ischemia followed by a 2-h reperfusion was modeled in anesthetized Wistar rats. Starting at the last minute of ischemia and during the first 9 min of reperfusion the rats in the control (n=8) and experimental (n=9) groups were injected with 0.9% NaCl and quinacrine solution (5 mg/kg), respectively. The area at risk and infarct size were evaluated by "double staining" with Evans blue and triphenyltetrazolium chloride. To assess vascular permeability in the area at risk zone, indocyanine green (ICG) and thioflavin S (ThS) were injected intravenously at the 90th and 120th minutes of reperfusion, respectively, to assess the no-reflow zone. The images of ICG and ThS fluorescence in transverse sections of rat hearts were obtained using a FLUM multispectral fluorescence organoscope. HR tended to decrease by 13% after intravenous administration of quinacrine and then recovered within 50 min. Quinacrine reduced the size of the necrotic zone (p=0.01), vascular permeability in the necrosis region, and the no-reflow area (p=0.027); at the same time, the area at risk did not significantly differ between the groups. Intravenous administration of quinacrine at the beginning of reperfusion of the rat myocardium reduces no-reflow phenomenon and infarct size.


Asunto(s)
Cardiotónicos , Daño por Reperfusión Miocárdica , Quinacrina , Ratas Wistar , Animales , Quinacrina/farmacología , Quinacrina/uso terapéutico , Daño por Reperfusión Miocárdica/tratamiento farmacológico , Daño por Reperfusión Miocárdica/patología , Ratas , Masculino , Cardiotónicos/farmacología , Cardiotónicos/uso terapéutico , Modelos Animales de Enfermedad , Permeabilidad Capilar/efectos de los fármacos , Infarto del Miocardio/tratamiento farmacológico , Infarto del Miocardio/patología , Miocardio/patología
2.
Bull Exp Biol Med ; 175(2): 219-224, 2023 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-37464198

RESUMEN

We studied the influence of recombinant IL-2 and brain-derived neurotrophic factor (BDNF) on the size of the myocardial necrosis zone of rats with systemic inflammatory response syndrome (SIRS). A significant increase in the necrosis zone and the levels of proinflammatory cytokines was revealed in animals with SIRS in comparison with the control. The administration of IL-2 to animals with SIRS significantly reduced the size of the necrosis zone, which was paralleled by a pronounced increase in IL-2 and BDNF in comparison with the corresponding parameters in rats with SIRS that did not receive IL-2. Administration of BDNF to animals with SIRS was followed by normalization of TNFα and IL-1α levels, but did not lead to a decrease in the size of the necrosis zone.


Asunto(s)
Infarto del Miocardio , Síndrome de Respuesta Inflamatoria Sistémica , Animales , Ratas , Interleucina-2/farmacología , Factor Neurotrófico Derivado del Encéfalo/farmacología , Infarto del Miocardio/complicaciones , Infarto del Miocardio/tratamiento farmacológico , Infarto del Miocardio/patología , Síndrome de Respuesta Inflamatoria Sistémica/complicaciones , Proteínas Recombinantes/farmacología , Peso Corporal , Conducta Alimentaria , Masculino , Ratas Wistar
3.
J Evol Biochem Physiol ; 58(6): 2058-2069, 2022.
Artículo en Inglés | MEDLINE | ID: mdl-36573161

RESUMEN

Numerous experimental and clinical studies have shown the effectiveness of various probiotic strains in metabolic disorders, gastrointestinal and liver diseases, immune system pathology. The effects of probiotics on cardiovascular dysfunction are less well known. The development and validation of a new experimental model in rats, including obesity, acute colon inflammation and antibiotic-induced dysbiosis, with common characteristics of systemic inflammatory response syndrome (SIRS), became the basis for investigating the effects of probiotic drugs on myocardial resistance to ischemic-reperfusion injury (IRI) using an in vivo model of infarction after coronary occlusion. A 24% increase in myocardial infarction compared to intact animals (p < 0.05) and significant changes in leukogram, biochemical and immunological parameters were found in Wistar rats with SIRS modelling. Introduction of a mixture of strains of Lactobacillus acidophilus (LA-5) and Bifidobacterium animalis subsp. lactis (BB-12) to animals with SIRS reduced infarct size to a value close to the control. Rats treated with LA-5 and BB-12 also showed normalization of the leukocyte count, bile acids, transforming growth factor-ß, interleukins: IL-1α, IL-2, IL-6, IL-8, tumor necrosis factor-α, lipopolysaccharide and monocyte chemoattractant protein-1 in blood in comparison with the SIRS group and with the groups treated with other probiotic strains. The obtained data convincingly show the prospects for further study of the cardiotropic potential of probiotic microorganisms in translational studies.

4.
Bull Exp Biol Med ; 174(2): 179-184, 2022 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-36600035

RESUMEN

We studied the role of both parts of the autonomic intracardiac nervous system in the pathogenesis of atrial fibrillation (AF). In 12 pigs weighing 39±3 kg, AF was induced by burst stimulation. Chemical inactivation of intrinsic cardiac neurons within the right atria was performed by transendocardial injections of liposomal neuromodulators into the dorsal part of the right atrial wall. Sympathetic and parasympathetic terminals were inactivated with 6-hydroxydopamine (6-OHDA, n=6) and ethylcholine aziridinium ion (AF64A, n=6), respectively. Neuromodulators were encapsulated in liposomes (LS) with diameters of 310±50 nm for OHDA and 290±50 nm for AF64A. LS-6-OHDA and LS-AF64A were injected into the ganglionated plexuses after measuring the baseline effective refractory period and assessing myocardial resistance to AF. These measurements were repeated 90 min after the injections. The optimal doses were 0.2 mg/kg for LS-6-OHDA and 0.4 mg/kg for LS-AF64A (in 4 ml of suspension). Immediately after injections of liposomal neuromodulators, almost all pigs showed an increase in HR, and a short-term BP elevation was observed in the LS-AF64A group. At the end of the experiment, similar decrease in the effective refractory period and similar increase in the resistance to AF were observed in all animals. Thus, selective chemical inactivation of cholinergic and adrenergic terminals of the intracardiac nervous system with liposomal neuromodulators increased the resistance to AF in an acute experiment. However, the short observation period does not allow making a definite conclusion about the role of the autonomic nervous system in the pathogenesis of AF, which requires verification of the obtained data in a chronic experiment.


Asunto(s)
Fibrilación Atrial , Animales , Porcinos , Fibrilación Atrial/inducido químicamente , Oxidopamina/farmacología , Atrios Cardíacos , Neurotransmisores/farmacología
5.
Bull Exp Biol Med ; 168(2): 210-213, 2019 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-31776951

RESUMEN

The effects of bariatric surgeries (sleeve gastrectomy and ileal transposition) on the dynamics of changes in ghrelin level were studied in rats with severe decompensated type 2 diabetes mellitus under conditions of glucose challenge as well as on the size of myocardial infarction in these animals. Diabetes was modelled by high fat diet and a single administration of streptozotocin (25 mg/kg, intraperitoneally). Both bariatric surgeries significantly decreased glucose-induced ghrelin level in the blood of rats with type 2 diabetes mellitus, which attested to an increase in the tissue sensitivity to ghrelin. Sleeve gastrectomy resulted in a decrease in the size of myocardial infarction in diabetic rats, which was calculated as the ratio of the necrosis zone to the zone of the risk of myocardial infarction. Ileal transposition had no effect on this parameter. Our data can be used as the basis for optimization of treatment approaches when using bariatric surgery in the treatment of patients with severe forms of type 2 diabetes mellitus with a high risk of cardiovascular diseases.


Asunto(s)
Cirugía Bariátrica/efectos adversos , Gastrectomía/efectos adversos , Ghrelina/sangre , Infarto del Miocardio/patología , Animales , Diabetes Mellitus Experimental/sangre , Diabetes Mellitus Tipo 2/sangre , Dieta Alta en Grasa , Modelos Animales de Enfermedad , Glucosa/administración & dosificación , Glucosa/metabolismo , Masculino , Ratas , Ratas Wistar , Estreptozocina
6.
Ross Fiziol Zh Im I M Sechenova ; 97(8): 814-23, 2011 Aug.
Artículo en Ruso | MEDLINE | ID: mdl-21961305

RESUMEN

The aim of this study was to evaluate the role of nitric oxide (NO) in the mechanisms of arterial distensibility and intravascular pressure stability in normotensive and spontaneously hypertensive rats. The experiments were performed on the anesthetized male Wistar, Wistar-Kyoto (WKY), and spontaneously hypertensive rats (SHR). The abdominal aorta was cannulated and perfused with variable blood flow rates with subsequent determination of major characteristics of regional vascular function. The blockade of nitric oxide (NO) synthase resulted in the increase in hydraulic resistance of the hindlimb vascular bed in all series of the experiments. It was associated with the decrease in the intravascular pressure stability. The obtained results provide further evidence for an important role of NO in the formation of conductivity and stability of the arterial pressure both in normo- and hypertensive rats. However, the involvement of NO in the phenomenon of flow-dependent vasodilation in SHR is unlikely. The major difference between SHR and normotensive rats involved the ability of the resistive arteries of SHR to enhance vascular conductivity in response to blood flow enhancement. Presumably, there are some unidentified additional factors that are involved in the flow-dependent vasodilation in SHR.


Asunto(s)
Inhibidores Enzimáticos/farmacología , Hipertensión/fisiopatología , Óxido Nítrico Sintasa/antagonistas & inhibidores , Óxido Nítrico/fisiología , Nitroarginina/farmacología , Resistencia Vascular/fisiología , Algoritmos , Animales , Arterias/fisiopatología , Presión Sanguínea , Cateterismo , Inhibidores Enzimáticos/efectos adversos , Hemodinámica , Hiperemia/inducido químicamente , Hiperemia/fisiopatología , Masculino , Óxido Nítrico Sintasa/metabolismo , Nitroarginina/efectos adversos , Ratas , Ratas Endogámicas SHR , Ratas Endogámicas WKY , Ratas Wistar , Vasodilatación/efectos de los fármacos
7.
Bull Exp Biol Med ; 152(1): 105-7, 2011 Nov.
Artículo en Inglés, Ruso | MEDLINE | ID: mdl-22803053

RESUMEN

Silica nanoparticles as carriers for targeted drug delivery to the heart were studied. Studies of hemodynamic parameters of rats after intravenous infusion of silica nanoparticles showed no acute toxicity. Intravenous infusion of silica nanoparticles to animals with ischemia-reperfusion of the myocardium led to accumulation of the nanoparticles in the focus of injury, which attests to possibility of passive targeted drug delivery to the myocardium.


Asunto(s)
Portadores de Fármacos/farmacocinética , Isquemia Miocárdica/tratamiento farmacológico , Dióxido de Silicio/farmacocinética , Animales , Presión Sanguínea/efectos de los fármacos , Portadores de Fármacos/toxicidad , Fluoresceína/farmacocinética , Colorantes Fluorescentes/farmacocinética , Frecuencia Cardíaca/efectos de los fármacos , Ensayo de Materiales , Miocardio/metabolismo , Nanopartículas , Tamaño de la Partícula , Ratas , Ratas Wistar , Dióxido de Silicio/toxicidad , Distribución Tisular
8.
Bull Exp Biol Med ; 151(3): 311-3, 2011 Jul.
Artículo en Inglés, Ruso | MEDLINE | ID: mdl-22451874

RESUMEN

The role of NO in the mechanism of quadropril modulation of the flow-dependent vasodilation was examined in normotensive (Wistar) and spontaneously hypertensive (SHR) rats. The abdominal aorta was cannulated and autoperfused at different volume rates to obtain the pressure-flow curves. In the first experimental series, the blood flow-pressure dependence was measured before and after intravenous injection of quadropril (1 mg/kg). In the next series, this dependence was obtained before and after injection of NO-synthase inhibitor L-NNA (10 mg/kg) and quadropril, respectively. Quadropril potentiated vasodilation caused by an increase in perfusion volume rate in both normo- and hypertensive rats and stabilized intravascular pressure. Inhibition of NO synthesis elevated hydraulic resistance and decreased stability of intravascular pressure in normo- and hypertensive rats. In normotensive rats, these changes were promoted by a decrease in vascular distensibility. Under these conditions, quadropril pronouncedly potentiated the flow-dependent vasodilation only in SHR rats, which was revealed methodically by an increase in perfusion rate in the posterior quarter of the body. Thus, in SHR rats the quadropril-potentiated vasodilation in response to increased perfusion rate does not depend on NO synthesis.


Asunto(s)
Inhibidores de la Enzima Convertidora de Angiotensina/farmacología , Enalapril/análogos & derivados , Hemodinámica/efectos de los fármacos , Hipertensión/fisiopatología , Óxido Nítrico/metabolismo , Vasodilatación/efectos de los fármacos , Animales , Velocidad del Flujo Sanguíneo/efectos de los fármacos , Presión Sanguínea/efectos de los fármacos , Enalapril/farmacología , Hipertensión/enzimología , Masculino , Óxido Nítrico/biosíntesis , Ratas , Ratas Endogámicas SHR , Ratas Wistar , Resistencia Vascular/efectos de los fármacos , omega-N-Metilarginina/farmacología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA